Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.99+0.09 (+3.10%)
Close on Nov 16, 2026Market cap $122.78MP/E –Yield –
Scienture gross margin
Gross margin is gross profit as a percentage of revenue.
Scienture's gross margin for the twelve months ending Sep 30, 2025 was 88.5%. For fiscal 2025 it was 76.8%, against 4.4% the year before. The highest annual figure on record is 100.0% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 76.8% | +72.4 |
| FY2024 | Dec 31, 2024 | 4.4% | +0.8 |
| FY2023 | Dec 31, 2023 | 3.6% | −50.3 |
| FY2022 | Dec 31, 2022 | 53.8% | +5.9 |
| FY2021 | Dec 31, 2021 | 48.0% | +14.7 |
| FY2020 | Dec 31, 2020 | 33.3% | −32.2 |
| FY2019 | Dec 31, 2019 | 65.5% | −22.8 |
| FY2018 | Dec 31, 2018 | 88.3% | −11.7 |
| FY2017 | Dec 31, 2017 | 100.0% | +0.0 |
| FY2016 | Dec 31, 2016 | 100.0% | +6.5 |
| FY2015 | Dec 31, 2015 | 93.5% | +22.9 |
| FY2014 | Dec 31, 2014 | 70.6% | +69.4 |
| FY2013 | Dec 31, 2013 | 1.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 97.7% | +92.4 |
| Q1 FY2026 | Mar 31, 2026 | 95.6% | +89.6 |
| Q3 FY2025 | Sep 30, 2025 | 97.4% | +101.1 |
| Q1 FY2025 | Mar 31, 2025 | 6.6% | +95.1 |
| Q4 FY2024 | Dec 31, 2024 | 5.3% | −4.8 |
| Q3 FY2024 | Sep 30, 2024 | 6.0% | −12.3 |
| Q2 FY2024 | Jun 30, 2024 | -3.8% | −18.6 |
| Q4 FY2023 | Dec 31, 2023 | -88.6% | −155.8 |
| Q3 FY2023 | Sep 30, 2023 | 10.1% | −56.7 |
| Q2 FY2023 | Jun 30, 2023 | 18.3% | −17.4 |
| Q1 FY2023 | Mar 31, 2023 | 14.8% | −26.4 |
| Q4 FY2022 | Dec 31, 2022 | 67.2% | +15.3 |
| Q3 FY2022 | Sep 30, 2022 | 66.8% | +16.5 |
| Q2 FY2022 | Jun 30, 2022 | 35.7% | −8.6 |
| Q1 FY2022 | Mar 31, 2022 | 41.2% | −4.1 |
| Q4 FY2021 | Dec 31, 2021 | 51.9% | +45.3 |
| Q3 FY2021 | Sep 30, 2021 | 50.2% | +19.8 |
| Q2 FY2021 | Jun 30, 2021 | 44.3% | +13.9 |
| Q1 FY2021 | Mar 31, 2021 | 45.3% | −29.1 |
| Q4 FY2020 | Dec 31, 2020 | 6.7% | −67.0 |
| Q3 FY2020 | Sep 30, 2020 | 30.5% | −26.2 |
| Q2 FY2020 | Jun 30, 2020 | 30.4% | −30.3 |
| Q1 FY2020 | Mar 31, 2020 | 74.4% | −1.4 |
| Q4 FY2019 | Dec 31, 2019 | 73.7% | +8.3 |
| Q3 FY2019 | Sep 30, 2019 | 56.7% | −43.0 |
| Q2 FY2019 | Jun 30, 2019 | 60.7% | −39.3 |
| Q1 FY2019 | Mar 31, 2019 | 75.8% | −24.2 |
| Q4 FY2018 | Dec 31, 2018 | 65.5% | −34.5 |
| Q3 FY2018 | Sep 30, 2018 | 99.7% | −0.3 |
| Q2 FY2018 | Jun 30, 2018 | 100.0% | +0.0 |
| Q1 FY2018 | Mar 31, 2018 | 100.0% | +0.0 |
| Q4 FY2017 | Dec 31, 2017 | 100.0% | −2.6 |
| Q3 FY2017 | Sep 30, 2017 | 100.0% | +0.0 |
| Q2 FY2017 | Jun 30, 2017 | 100.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 100.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 102.6% | – |
| Q3 FY2016 | Sep 30, 2016 | 100.0% | – |
See a number that looks wrong?